(Q37382114)

20 August 2017

1 reference

title

Intraocular sustained-release delivery systems for triamcinolone acetonide (English)

1 reference

20 August 2017

Saffar Mansoor

1

1 reference

20 August 2017

Baruch D Kuppermann

series ordinal

2

1 reference

20 August 2017

M Cristina Kenney

series ordinal

3

1 reference

20 August 2017

publication date

28 January 2009

1 reference

20 August 2017

published in

Pharmaceutical Research

1 reference

20 August 2017

volume

26

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

770-784

1 reference

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

Development, implantation, in vivo elution, and retrieval of a biocompatible, sustained release subretinal drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

A biodegradable drug delivery system for the treatment of postoperative inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-008-9812-Z

Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients

21 January 2018

1 reference

12 December 2020

An update of treatment options for neovascular age-related macular degeneration.

1 reference

12 December 2020

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

1 reference

12 December 2020

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion

1 reference

12 December 2020

Biodegradable scleral implants as new triamcinolone acetonide delivery systems.

1 reference

12 December 2020

Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases

1 reference

12 December 2020

Current treatment approaches in diabetic macular edema

1 reference

12 December 2020

Visualizing vitreous using Kenalog suspension

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial

1 reference

12 December 2020

Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells

1 reference

12 December 2020

Triamcinolone acetonide in ocular therapeutics

1 reference

12 December 2020

Biodegradable microspheres for vitreoretinal drug delivery

1 reference

12 December 2020

Intravitreal steroids for macular edema: the past, the present, and the future

1 reference

12 December 2020

Application of encapsulated cell technology for retinal degenerative diseases

1 reference

12 December 2020

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

1 reference

12 December 2020

Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications

1 reference

12 December 2020

A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis

1 reference

12 December 2020

Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: short-term optical coherence tomography results

1 reference

12 December 2020

A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration

1 reference

12 December 2020

Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres

1 reference

12 December 2020

Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles

1 reference

12 December 2020

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

1 reference

12 December 2020

Time course and morphology of vascular effects associated with photodynamic therapy

1 reference

12 December 2020

Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification

1 reference

12 December 2020

Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus.

1 reference

12 December 2020

Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process

1 reference

12 December 2020

Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis

1 reference

12 December 2020

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes

1 reference

12 December 2020

Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy

1 reference

12 December 2020

Diabetic macular edema: classification, medical and laser therapy

1 reference

12 December 2020

Adhesion molecules are expressed in the human retina and choroid

1 reference

12 December 2020

Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor.

1 reference

12 December 2020

Topical and systemic drug delivery to the posterior segments

1 reference

12 December 2020

Use of surodex in phacotrabeculectomy surgery.

1 reference

12 December 2020

Drug delivery systems for vitreoretinal diseases

1 reference

12 December 2020

Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions

1 reference

12 December 2020

Microspheres of biodegradable polymers as a drug-delivery system in the vitreous

1 reference

12 December 2020

Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone

1 reference

12 December 2020

Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

12 December 2020

Guidance for the treatment of neovascular age-related macular degeneration

1 reference

12 December 2020

Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy

1 reference

12 December 2020

Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression

1 reference

12 December 2020

Intralesional corticosteroid therapy of chalazia

1 reference

12 December 2020

Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging

1 reference

12 December 2020

Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

1 reference

12 December 2020

Intraocular implants for extended drug delivery: therapeutic applications.

1 reference

12 December 2020

Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A.

1 reference

12 December 2020

Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy

1 reference

12 December 2020

Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion

1 reference

12 December 2020

Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period

1 reference

12 December 2020

Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis

1 reference

12 December 2020

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment

1 reference

12 December 2020

Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells

1 reference

12 December 2020

Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration

1 reference

12 December 2020

Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR)

1 reference

12 December 2020

Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.

1 reference

12 December 2020

An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy

1 reference

12 December 2020

Anti-proliferative effects of deflazacort on Nb2 cells as quantitated by formazan production

1 reference

12 December 2020

Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugate

1 reference

12 December 2020

Intraocular sustained drug delivery using implantable polymeric devices

1 reference

12 December 2020

Ganciclovir implant exchange. Timing, surgical procedure, and complications

1 reference

12 December 2020

Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.

1 reference

12 December 2020

Management of neovascular age-related macular degeneration

1 reference

12 December 2020

The lack of toxicity of intravitreally administered triamcinolone acetonide

1 reference

12 December 2020

Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation

1 reference

12 December 2020

Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection

1 reference

12 December 2020

Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.

1 reference

12 December 2020

In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release

1 reference

12 December 2020

Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.

1 reference

12 December 2020

Combination therapy for the treatment of ocular neovascularization

1 reference

12 December 2020

Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor

1 reference

12 December 2020

Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants.

1 reference

12 December 2020

The selection of adrenocorticosteroid preparations

1 reference

12 December 2020

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

1 reference

12 December 2020

Intravitreal triamcinolone acetonide in exudative age-related macular degeneration

1 reference

12 December 2020

Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis.

1 reference

12 December 2020

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study

1 reference

12 December 2020

Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin

1 reference

12 December 2020

Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome

1 reference

12 December 2020

Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor

1 reference

12 December 2020

Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium

1 reference

12 December 2020

Intravitreal triamcinolone for refractory pseudophakic macular edema.

1 reference

12 December 2020

Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy

1 reference

12 December 2020

Intravitreal Sustained-Release Ganciclovir

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study

1 reference

12 December 2020

Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration

1 reference

12 December 2020

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis

1 reference

12 December 2020

10.1007/S11095-008-9812-Z

Identifiers

DOI

1 reference

20 August 2017

1 reference